本页面由Tiger Trade Technology Pte. Ltd.提供服务

天演药业

2.76
-0.0200-0.72%
盘后:2.760.00000.00%19:30 EDT
成交量:164.93万
成交额:443.78万
市值:1.85亿
市盈率:-7.32
高:2.87
开:2.76
低:2.63
收:2.78
52周最高:4.85
52周最低:1.30
股本:6,714.33万
流通股本:4,220.06万
量比:6.59
换手率:3.91%
股息:- -
股息率:- -
每股收益(TTM):-0.3773
每股收益(LYR):-0.3750
净资产收益率:-28.50%
总资产收益率:-13.95%
市净率:2.07
市盈率(LYR):-7.36

数据加载中...

2026/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/01

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/01/08

SEC问询函

Form CORRESP - Correspondence
2025/05/28

SEC问询函

Form CORRESP - Correspondence
2025/05/23

SEC问询函

Form CORRESP - Correspondence
2025/03/24

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/07

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/03/29

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/01

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/19

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/07/10

SEC问询函

Form CORRESP - Correspondence
2023/06/16

SEC问询函

Form CORRESP - Correspondence
2023/04/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/05/24

SEC问询函

CORRESP [Cover] - Correspondence
2022/05/13

SEC问询函

CORRESP [Cover] - Correspondence